Tools chosen: polymarket_direct polymarket_related kalshi_related claude_news gdelt_news wikipedia earnings_data code_execution

Sub-questions (Fermi decomposition)

Planner reasoning

This is a conditional-on-IPO bracket question: it requires both that Oura IPOs before 2027 and that its closing day-one market cap lands in the narrow $12.5B–$15B band. Key research is (a) the Polymarket price anchor and sibling bracket prices, (b) whether Oura has filed/confidentially filed an S-1 or signaled 2026 IPO timing, and (c) its latest private valuation ($11B in late-2025 round) to place the bracket relative to the likely pricing distribution.

# Current state Oura confidentially filed a draft registration statement (S-1) with the SEC on 2026-05-21, targeting a US listing "later in 2026," with Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co., and Jefferies as underwriters. No price range, share count, or firm listing date has been disclosed; the deal remains subject to SEC review and market conditions. Resolution requires an actual IPO close before 2027-01-01 ET, with a specific market-cap bracket ($12.5B–$15B) — a fairly narrow ~20% band above the last known private valuation of ~$11B. # Timeline of key events - 2024-12: Oura raises private round at ~$5.2B valuation (Sacra, confirmed). - 2025-10: Oura raises $900M Series E led by Fidelity at ~$11B valuation, total capital raised ~$1.5B (Sacra/BioWorld, confirmed). - 2025-11: CEO Tom Hale tells CNBC Oura is on track for ~$1B 2025 revenue, projecting ~$2B in 2026 sales (CNBC, confirmed). - 2026-01: Bloomberg reports Oura planning a tender offer for existing investors at ~25% discount to Series E price (implying ~$8.25B secondary valuation) — reported, not company-confirmed. - 2026-03: Comparable wearables firm Whoop raises Series G at $10.1B valuation (CNBC, confirmed). - 2026-05-21: Oura confidentially files for US IPO with SEC; underwriters named; no pricing details (CNBC/Bloomberg/Forbes, confirmed filing, timeline "later in 2026" is company-stated but flexible). - 2026-05-28: Oura Ring 5 launches at $399, ahead of IPO (WWD/TheNextWeb, confirmed product event, unrelated to pricing). - 2026-06 to 2026-08: Ongoing product coverage; no further IPO pricing/date news surfaced in research window. # Event Will Oura's market cap land in the $12.5B–$15B bracket at the close of its first trading day (resolves "No IPO before 2027" if no IPO by 2026-12-31). # Outcomes to forecast Yes / No (this bracket specifically; sibling brackets and "no IPO" exist as separate Polymarket outcomes) # Kalshi market anchor No Kalshi-direct data found for this specific ticker (kalshi_related search for "Oura" returned no matches). Polymarket is the only direct pricing source available: current YES = **10.5%**, down 6pts over 7 days, up 2pts over 30 days; volume only $50.6K (thin), 81-day price history ranging 7%–49% (suggesting the market has repriced substantially, likely down from an early speculative high toward more sober valuation modeling post-S-1 filing). # Sub-question answers 1. **Polymarket YES / sibling brackets / no-IPO implied prob** — This bracket trades at 10.5%; no sibling bracket or "no IPO" data was retrieved, but the wide historical range (7%–49%) implies the market has re-priced the whole distribution repeatedly as news emerged. 2. **S-1 filing / timeline** — Confirmed confidential S-1 filing 2026-05-21; underwriters named (Goldman, Morgan Stanley, JPMorgan, Allen & Co., Jefferies); company states listing planned "later in 2026" but no fixed date/price range disclosed, subject to SEC review and market conditions (CNBC, Bloomberg, Forbes). 3. **Last private valuation/revenue** — Oct 2025 Series E at ~$11B (up from $5.2B in Dec 2024); ~$1B 2025 revenue, ~$2B projected 2026 revenue per CEO Tom Hale (CNBC, Sacra, BioWorld). 4. **IPO pop ratios for comparable hardware/health-tech** — Peloton listed 2019 at $8.1B; Fitbit 2015 at ~$4.1B; no systematic day-one-close/last-private-valuation ratio data was retrieved (FMP historical data blocked by 403 errors for GRMN/PTON/MASI). 5. **Conditional probability bracket hit** — Model estimate (lognormal, median 1.0–1.4x last private mark, σ 0.35–0.55): P(bracket | IPO occurs) ≈ 13–20%, base case ~16%. 6. **Macro/IPO window** — 2026 IPO pipeline described as "surging" (SpaceX, OpenAI filings same week); Whoop raised at $10.1B in March 2026, suggesting wearables cluster near $10–11B privately, a soft ceiling reference for IPO-day pricing (CNBC, Forbes). # Key facts (high-confidence, factual) 1. [CNBC/Bloomberg] Confidential S-1 filed 2026-05-21; no price range/share count yet. 2. [Sacra/BioWorld] Last private valuation ~$11B (Oct 2025 Series E, $900M raised). 3. [Bloomberg via Sacra] Jan 2026 tender offer reportedly at ~25% discount to Series E (~$8.25B implied) — reported, not confirmed by Oura. 4. [CNBC] Whoop (comparable) valued at $10.1B (March 2026 private round). 5. [Forbes] A successful Oura IPO would be largest consumer-wearables IPO since Peloton (2019, $8.1B) and Fitbit (2015, $4.1B). 6. [Polymarket] This specific bracket YES = 10.5%, thin volume ($50.6K), high historical volatility (7%-49%). # Cross-market signals - Kalshi related: No direct Oura market found; general IPO-race markets (Ramp/Brex, OpenAI/Anthropic) show unrelated dynamics, not useful comparables. - Polymarket: 10.5% YES for this bracket, down from a 49% historical high — market has substantially discounted this specific range as more information (tender offer discount, no pricing yet) emerged. - Sportsbook implied: N/A (not applicable to this event type). # Analyst opinions and speculation - Forbes/CNBC framing treats Oura as a marquee 2026 IPO alongside SpaceX/OpenAI, implying strong institutional demand could push pricing above last private mark. - The Jan 2026 tender-offer report (Bloomberg) is a bearish secondary-market signal (~$8.25B), in tension with bullish revenue growth narrative — unresolved conflict between "hot IPO market" framing and discounted insider liquidity pricing. - Code-execution model treats P(IPO before 2027) as the dominant uncertainty (linear driver), with conditional bracket-hit probability comparatively stable (~13–20%) regardless of assumptions. # Directional lean per outcome - **Yes ($12.5B–$15B)**: Supported by strong revenue growth (~$1B→$2B), hot 2026 IPO pipeline framing, Peloton/Fitbit precedent of premium-to-recent-round pricing. Opposed by: no fixed timeline/price range yet, thin/declining Polymarket price (10.5%), reported discounted tender offer (~$8.25B) suggesting downside valuation risk, and narrow bracket width relative to wide plausible outcome distribution. - **No**: Supported by Polymarket pricing this bracket at just 10.5%, uncertainty over IPO timing (SEC review still pending, no confirmed 2026 close date), and modeled unconditional probability range of ~1–8% (base case ~3-6%) once P(IPO before 2027) is folded in. # Gaps / unknowns - No confirmed IPO date, price range, or share count as of latest research (Aug 2026 news cutoff). - No Kalshi-direct price found for this exact ticker; relying solely on Polymarket as anchor. - No sibling-bracket or "no IPO" Polymarket data retrieved to triangulate full outcome distribution. - FMP comparable-company historical data (GRMN, PTON, MASI) blocked by API errors — limits precision on IPO-pop ratio analysis. - Tender offer report unconfirmed by company; conflicts with bullish valuation narrative. # Calibration anchors - Polymarket current YES price (anchor): **10.5%** for this specific bracket. - Model-derived unconditional probability range: ~1.2%–8.2% across assumption grid; base-case point estimate ~4-6%. - Precedents: Peloton (2019) and Fitbit (2015) both priced IPOs below or near recent private marks in several cases, cautioning against assuming automatic IPO "pop" to $12.5B+ from an ~$11B last private valuation.

1. Both forecasters converge tightly around 7-9%, slightly under the Polymarket anchor (10.5%), but neither explores why they should deviate from a thin, volatile market ($50.6K volume, 7%-49% range) — with such low liquidity and wide historical swings, the anchor itself may be noisy and unreliable, yet both treat it as a firm ceiling to shade below rather than flagging the wide error bars on the anchor itself. 2. Neither forecast seriously grapples with the missing sibling-bracket/no-IPO Polymarket data (explicitly flagged as a gap), meaning they cannot verify whether 10.5% for this bracket is internally consistent with the rest of the distribution — an inconsistency check that could reveal mispricing either direction. 3. Both forecasters adopt P(IPO by year-end) implicitly in the 50-60% range without citing direct evidence for this figure; the brief's own model treats "P(IPO before 2027) as the dominant uncertainty" yet neither forecast stress-tests low-end scenarios (e.g., SEC review delays or 2027 slip, common for confidential filings without a disclosed price range even by Aug 2026, three months post-filing). 4. Neither forecast addresses the tension between the "hot IPO market" narrative (SpaceX/OpenAI filing same week, bullish revenue trajectory to $2B) and the bearish tender-offer discount signal in a differentiated way — both just average the conflict into a similar ~13-20% conditional estimate without exploring whether one signal (e.g., recent CEO revenue guidance) should dominate given recency. 5. The precedent evidence (Peloton, Fitbit both priced at or below recent private marks) is mentioned but underweighted as a base-rate anchor; if hardware/wearables IPOs systematically underprice relative to last private round, this argues for a distribution centered below $11B, potentially pushing more mass to a lower bracket rather than symmetric treatment implied by the lognormal model (median 1.0-1.4x). 6. Both forecasts collapse to nearly identical point estimates (9% vs 7%) despite claiming independent reasoning, suggesting insufficient exploration of tail scenarios — e.g., a mega-upsized "hot IPO" pop (Forbes framing alongside SpaceX/OpenAI) that could push above $15B, which neither forecast discusses as a competing tail risk to the No case beyond the bracket itself.

8% (50% confidence)

Yes: 8% No: 92%

Two conditions must both hold: an actual IPO closing before 2027-01-01 (only a confidential S-1 with no price range, share count, or date as of the Aug 2026 window — realistically ~50-60%, with real slip-to-2027 risk) and landing in a narrow ~20% band above the ~$11B last private mark. Conditional bracket-hit modeling gives ~13-20%, implying an unconditional ~7-11%, while the brief's own model grid points lower (~4-6%). The bearish signals (reported ~$8.25B tender at a 25% discount, Whoop's $10.1B comp, and the Peloton/Fitbit precedent of pricing at or below last private marks) suggest the distribution centers at or below $11B, shifting mass to lower brackets; the bullish revenue trajectory ($1B→$2B) and hot 2026 pipeline keep meaningful mass above $12.5B, including some above $15B. The thin, volatile Polymarket anchor (10.5%, $50.6K volume, 7-49% range) is noisy, so I don't treat it as a firm ceiling, but its direction is consistent with a modest single-digit-to-low-teens estimate. I settle at 8%, essentially at the consensus midpoint but explicitly acknowledging wide error bars around the anchor.

Total pipeline time: 306.3s